Why Intuitive Surgical Is Poised to Outperform
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, surgical-robot specialist Intuitive Surgical has earned a respected four-star ranking.
With that in mind, let's take a closer look at Intuitive and see what CAPS investors are saying about the stock right now.
Sunnyvale, Calif. (1995)
Health care equipment
CEO Gary Guthart (since 2010)
Return on Equity (average, past 3 years)
Cash / Debt
$1.1 billion / $0
Sources: S&P Capital IQ and Motley Fool CAPS.
On CAPS, 95% of the 4,361 members who have rated Intuitive believe the stock will outperform the S&P 500 going forward.
Even if the economy sees sales stymied now, that will change over time. I think the biggest predictor of success over the long term is the fact that new doctors are trained on the DaVinci extensively and actually rely on it. In our hospital, the urologists are having a very tough time recruits new partners because the hospital does not have a DaVinci and the doctors fresh out of residency don't want to come work without it. Even though it is expensive, it is the way that trends are going now. Most large [hospitals] are going to need one in the next 5 years.
Intuitive Surgical is disruptive innovator. A true renegade in the health care industry, the company rebelled against the status quo to lead a revolution in medical robotics. Early investors experienced unimaginable gains, some making as much as 30 times their initial investment. Even with those enormous gains in the rearview mirror, the stock could have plenty of room to run into the future. In a brand new premium report on Intuitive Surgical, we've commissioned Karl Thiel to outline the company's key opportunities and risks with surgical precision. As one of the minds behind our Rule Breakers recommendation of the stock in 2005 (before it went on to gain more than 1,000%) Thiel knows the Intuitive Surgical story inside and out. It's a must-read for any current or prospective investor, and comes loaded with a full year of analyst updates. Make sure to claim your copy today by clicking here now.
Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.
The article Why Intuitive Surgical Is Poised to Outperform originally appeared on Fool.com.Fool contributor Brian Pacampara has no positions in the stocks mentioned above. The Motley Fool owns shares of Intuitive Surgical and Medtronic and has the following options: short MAY 2013 $44.00 calls on Medtronic. Motley Fool newsletter services recommend Intuitive Surgical. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.